Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Measles has killed nearly three times as many people in Congo than an Ebola outbreak in the country that has garnered far more international attention, particularly after health teams came under attack from armed militias operating in the area. “Lack of funding remains a huge impediment to successfully curbing the outbreak,” WHO said in announcing its appeal. While $27.6 million already has been mobilized to curb the measles epidemic, WHO said that $40 million is needed for a special six-month plan to vaccinate older children between the ages of 6 and 14. A vaccine against measles has existed for decades but some 310,000 cases have been reported in Congo since the beginning of 2019. Health workers in Congo struggle to access remote parts of the vast country, and vaccination rates remain low in areas where armed groups operate. Many health resources in Congo this year also have been devoted to the simultaneous outbreak of Ebola, which has become the second worst in history after the 2014-2016 West Africa epidemic. At least 2,231 people have died of Ebola since that outbreak was first identified in August 2018. Claim: WHO: Death toll from measles outbreak in Congo hits 6,000.
The death toll from a measles epidemic in Congo has surpassed 6,000, the World Health Organization said Tuesday as it warned that more funds are needed to save lives during the world’s worst outbreak of the infectious disease.

Paragraph: Phusion Projects LLC, which is based in Chicago, agreed not to sell caffeinated alcoholic drinks, agreed not to promote binge drinking or other misuses of alcohol, and accepted marketing limits designed to keep people under 21 from buying alcoholic products. Among these limits are a ban on promoting flavored malt beverages on school or college property except at licensed retailers, and not using models or actors under age 25 or who appear to be under age 21 in its advertising. Phusion also agreed to pay $400,000 to the regulators as part of the settlement. The danger of mixing caffeine and alcohol was spotlighted in 2010 when some college students were hospitalized for alcohol poisoning after drinking alcoholic energy drinks. Phusion that year removed the caffeine and other stimulants from beverages, including Four Loko, after the U.S. Food and Drug Administration warned the company and rivals that “blackout in a can” drinks combining alcohol and caffeine were unsafe. “Alcoholic energy drinks are dangerous - especially for the teenagers and young adults they target,” New York Attorney General Eric Schneiderman said in a statement. “Today’s agreement ensures that one company will no longer market a dangerous product to youth.”  In the settlement, Phusion denied the regulators’ allegations and that it violated any laws, including state laws governing consumer protection and trade practices. “We consider this agreement a practical way to move forward and an opportunity to highlight our continued commitment to ensuring that our products are consumed safely and responsibly only by adults 21 and over,” President Jim Sloan said in a statement. “Phusion continues to believe, however, as do many people throughout the world, that the combination of alcohol and caffeine can be consumed safely and responsibly.” Claim: Maker of Four Loko flavored malt liquor accepts marketing limits.
The maker of Four Loko has agreed with 20 U.S. state attorneys general and the city of San Francisco to a series of reforms to resolve allegations that it improperly marketed flavored malt beverages to young people and encouraged alcohol abuse.

Paragraph: File photo shows the silhouette of an elderly man. Reuters/File  They said people who took drugs that block acetylcholine —  a chemical messenger in the nervous system critical for memory  — functioned less well than their peers. “These results were true even in older adults who have  normal memory and thinking abilities,” said Dr. Kaycee Sink of  Wake Forest University School of Medicine in North Carolina,  who led the study of 3,000 people of whom 40 percent were  taking more than one anticholinergic drug. “The effect is essentially that of a three- to four-year  increase in age. So someone who is 75 in our study and taking  at least one moderately anticholinergic medication is at a  similar functional level to a 78 to 79-year-old,” Sink said in  an e-mail. Sink’s findings, presented at American Geriatrics Society  Meeting in Washington, add to a growing body of research that  suggests these so-called anticholinergic medications can hasten  functional and cognitive declines in elderly people. Some of the most common such drugs in the study included  the blood pressure drug nifedipine (sold as Adalat or  Procardia), the stomach antacid ranitidine or Zantac, both with  mild or moderate anticholinergic properties, and Pfizer Inc’s  incontinence drug tolterodine or Detrol, which is highly  anticholinergic. “The tricky part ... is that many useful drugs from many  different classes of medications have anticholinergic  properties,” Sink said. She said in many cases newer drugs are available that do  not have these effects and said doctors should look out for  them for elderly patients. Dr. Jack Tsao, a neurologist with the U.S. Navy, reported  last month at a American Academy of Neurology meeting that  elderly people who took anticholinergic drugs had a 50 percent  greater rate of memory decline than people in a long-term study  who did not take the drugs. Sink studied the effects of taking multiple anticholinergic  drugs on walking speed, basic activities such as dressing,  eating, taking care of personal hygiene, grooming, and harder  activities like shopping, cooking and managing money on her  test subjects whose average age was 78. The researchers found that the more anticholinergic drugs  people had in their systems, the worse their physical function,  based on reports from people in the study and on independent  measures of their performance. In a separate study this month in the Journal of the  American Geriatrics Society, Sink found that older nursing home  residents who took drugs for dementia and incontinence at the  same time had a 50 percent faster decline in function than  those treated only for dementia. “I would encourage patients to bring in a list of  everything they take (even over-the-counter medications) to  their doctor and have them review it at least yearly,” Sink  said. “Physicians should try to decrease anticholinergic burden  whenever possible.” Claim: Common drugs hasten decline in elderly: study.

Elderly people who took commonly  prescribed drugs for incontinence, allergy or high blood  pressure walked more slowly and were less able to take care of  themselves than others not taking the drugs, U.S. researchers  said on Saturday.